Nuzyra OverviewOmadacycline, sold under the brand name Nuzyra, is a broad spectrum antibiotic medication belonging to the aminomethylcycline subclass of tetracycline antibiotics. In the United States, it was approved in October 2018, for the treatment of community-acquired bacterial pneumonia and acute skin and skin structure infections. Contents 1 In vitro studies 2 Mechanism of action 3 Clinical trials 4 Discovery 5 References 6 External links In vitro studies In vitro studies h...
Read more Nuzyra Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Omadacycline
Recent Nuzyra Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Powder: 100mg/vial
- Tablet: 150mg
NDC Database Records for Nuzyra: (2 results)Sorted by National Drug Code
- 71715-001 Nuzyra 100 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Paratek Pharmaceuticals, Inc.
- 71715-002 Nuzyra 150 mg Oral Tablet, Film Coated by Paratek Pharmaceuticals, Inc.